Menu
Subscribe to our Email Alerts
Home
About Us
Company Overview
Our Values
Board of Directors
Management
Scientific Advisory Board
Corporate Directory
Corporate Governance
Pipeline
Background - FAK
Background - Fibrotic Cancers
Background - Fibrosis
Our FAK Inhibitors
Investor Information
Welcome
Investor Fact Sheet
Investor Presentation
Media
Research Reports
Top 20 Shareholders
Shareholder Services
Investor FAQs
US Shareholders
Announcements and Reports
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
Contact Us
Contact Us
Email Alerts
Announcements and Reports
Home
>
Announcements and Reports
>
ASX Announcements
ASX Announcements
Annual Reports
Half Yearly Reports
Quarterly Reports
ASX Announcements
Filter by Year:
2021
2020
2019
2018
24-Jun-2019
Dr John Lambert appointed as new CEO
17-Jun-2019
Preliminary Rights Issue Details
14-Jun-2019
Placement Cleansing Notice
14-Jun-2019
Appendix 3B - Placement $360k
12-Jun-2019
Capital Raising for Clinical-Enabling Studies
29-May-2019
Preliminary Final Report - Year Ended 31 March 2019
30-Apr-2019
Appendix 4C - Quarterly Statement of Cash Flows
1-Apr-2019
European Patent Completes IP Protection in Major Markets
11-Mar-2019
Amplia Expands Advisory Board
12-Feb-2019
Update - February 2019 Newsletter
Previous
1
2
3
4
